Table 5

Univariate and enter multivariate Cox hazard analysis for the predictors of 6-month mortality

Univariate analysisMultivariate analysis
OR (95% CI)P valueOR (95% CI)P value
Age1.01 (0.99 to 1.03)0.181.01 (0.99 to 1.03)0.37
NT-proBNP2.44 (1.37 to 4.35)0.0020.88 (0.45 to 1.72)0.71
cTNI-ultra0.88 (0.53 to 1.49)0.64
LVEF0.99 (0.95 to 1.02)0.35
Paroxysmal AF4.04 (2.00 to 8.14)<0.0011.43 (0.65 to 3.18)0.37
Persistent AF5.93 (3.36 to 10.46)<0.0012.36 (1.22 to 4.55)0.011
Ischaemic heart disease3.02 (1.88 to 4.86)<0.0012.40 (1.43 to 3.99)0.001
Malignancy2.82 (1.71 to 4.67)<0.0012.77 (1.57 to 4.87)<0.001
Septicaemia1.45 (0.75 to 2.81)0.27
COPD1.48 (0.74 to 2.95)0.27
Pulmonary artery hypertension1.50 (0.80 to 2.84)0.21
History of VTE0.70 (0.42 to 1.15)0.16
Cerebral infarction2.22 (1.34 to 3.67)0.0021.93 (1.09 to 3.40)0.023
Diabetes1.38 (0.56 to 3.41)0.49
Pulmonary infection1.36 (0.87 to 2.12)0.18
Chronic cor pulmonale1.90 (0.83 to 4.35)0.13
Congestive heart failure4.06 (2.64 to 6.24)<0.0012.50 (1.51 to 4.12)<0.001
Massive PE3.50 (1.98 to 6.19)<0.0012.76 (1.51 to 5.03)0.001
Submassive PE0.69 (0.38 to 1.27)0.240.68 (0.36 to 1.29)0.24
  • cTnI-ultra; cardiac troponin I ultra; AF, atrial fibrillation; COPD, chronic obstructive pulmonary disease; LVEF, left ventricular ejection fraction; NT-proBNP, amino-terminal pro-brain natriuretic peptide; PE, pulmonary embolism; VTE, venous thromboembolism.